ASCO® GI 2025 Insights: Safety, Efficacy, and ctDNA Changes of RMC-6236, a RAS(ON) Multi-Selective Inhibitor, in R/R RAS-Mutant PDAC | VuMedi

Find latest Pancreatic Cancer videos · 100+ videos

Video Player is loading.

Current Time 0:00

Duration 0:00

Loaded: 0%

Stream Type LIVE

Remaining Time 0:00

10 seconds

Playback speed

This video is featured in the Insights from 2025 ASCO® GI Annual Meeting

Insights from 2025 ASCO® GI Annual Meeting

ASCO® GI 2025 Insights: Safety, Efficacy, and ctDNA Changes of RMC-6236, a RAS(ON) Multi-Selective Inhibitor, in R/R RAS-Mutant PDAC

By Insights from 2025 ASCO® GI Annual Meeting FEATURING Ignacio Garrido-Laguna

By Insights from 2025 ASCO® GI Annual Meeting FEATURING Ignacio Garrido-Laguna

66 views

February 18, 2025

Comments 0

Login to view comments. Click here to Login